Para a preparação EUDR, o código SH/NC 300360 está classificado como fora do âmbito.
Medicaments containing any of the following antimalarial active principles: artemisinin (INN) for oral ingestion combined with other pharmaceutical active ingredients, or amodiaquine (INN); artelinic acid or its salts; artenimol (INN); artemotil (INN); artemether (INN); artesunate (INN); chloroquine (INN); dihydroartemisinin (INN); lumefantrine (INN); mefloquine (INN); piperaquine (INN); pyrimethamine (INN) or sulfadoxine (INN), not containing hormones, steroids used as hormones or antibiotics, not in measured doses or put up for retail sale O motor de âmbito indexado devolve Out of scope para este código. No Annex I scope match was found for this indexed CN code.
Porque é que esta página de referência dá essa resposta.
- Descrição do código
- Medicaments containing any of the following antimalarial active principles: artemisinin (INN) for oral ingestion combined with other pharmaceutical active ingredients, or amodiaquine (INN); artelinic acid or its salts; artenimol (INN); artemotil (INN); artemether (INN); artesunate (INN); chloroquine (INN); dihydroartemisinin (INN); lumefantrine (INN); mefloquine (INN); piperaquine (INN); pyrimethamine (INN) or sulfadoxine (INN), not containing hormones, steroids used as hormones or antibiotics, not in measured doses or put up for retail sale
- Base no anexo I
- Sem entrada direta no anexo I
- Base da fonte
- Regulation (EU) 2023/1115 Annex I and CN 2026 index
Linhas ascendentes, descendentes e próximas.
A vista de biblioteca destina-se à navegação de referência. Use o verificador quando quiser executar outro código como ação.
30produtos farmacêuticosout3003medicaments consisting of two or more constituents mixed together for therapeutic or prophylactic uses, not in measured doses or put up for retail sale (excl. goods of heading 3002, 3005 or 3006)out30036000medicaments containing any of the following antimalarial active principles: artemisinin (inn) for oral ingestion combined with other pharmaceutical active ingredients, or amodiaquine (inn); artelinic acid or its salts; artenimol (inn); artemotil (inn); artemether (inn); artesunate (inn); chloroquine (inn); dihydroartemisinin (inn); lumefantrine (inn); mefloquine (inn); piperaquine (inn); pyrimethamine (inn) or sulfadoxine (inn), not containing hormones, steroids used as hormones or antibiotics, not in measured doses or put up for retail saleout300310medicaments containing penicillins or derivatives thereof with a penicillanic acid structure, or streptomycins or derivatives thereof, not in measured doses or put up for retail saleout300320medicaments containing antibiotics, not in measured doses or put up for retail sale (excl. medicaments containing penicillins or derivatives thereof with a penicillanic acid structure, or streptomycins or derivatives thereof)out300331medicaments containing insulin, not in measured doses or put up for retail saleout300339medicaments containing hormones or steroids used as hormones, not containing antibiotics, not in measured doses or put up for retail sale (excl. those containing insulin)out300340medicaments containing alkaloids or derivatives thereof, not containing hormones, steroids used as hormones or antibiotics, not in measured doses or put up for retail saleout300341medicaments containing ephedrine or its salts, not containing hormones, steroids used as hormones or antibiotics, not in measured doses or put up for retail saleout
O que isto significa para a preparação.
Esta linha não desencadeia diretamente a recolha de provas no resultado de âmbito atual.
Regulation (EU) 2023/1115 Annex I — relevant productsobtido em 2026-08-06Commission Delegated Regulation (EU) 2026/2102 amending Annex I to Regulation (EU) 2023/1115obtido em 2026-09-24Eurostat Comext Combined Nomenclature codelist (CXT_NC v11.0)obtido em 2026-08-06Eurostat Comext partner country codelist (CXT_FREE_ISO)obtido em 2026-08-06Eurostat Comext DS-045409 — EU trade since 1988 by HS2-4-6 and CN8obtido em 2026-08-06Commission Implementing Regulation (EU) 2025/1093 — country benchmarkingobtido em 2026-08-06Regulation (EU) 2025/2650 amending Regulation (EU) 2023/1115 as regards certain obligations of operators and tradersobtido em 2025-12-26Commission Implementing Regulation (EU) 2026/1565 amending Implementing Regulation (EU) 2024/3084 (EUDR information system)obtido em 2026-08-08